ADDITIONAL EVIDENCE FOR THE AUGMENTED INDUCTION OF TUMOR-SPECIFIC RESISTANCE IN VACCINIA VIRUS-PRIMED MICE BY IMMUNIZATION WITH VACCINIA VIRUS-MODULATED SYNGENEIC TUMOR-CELLS

被引：0
|
作者：
UEDA, S [1 ]
WAKAMIYA, N [1 ]
WU, KS [1 ]
KATO, S [1 ]
FUJIWARA, H [1 ]
HAMAOKA, T [1 ]
机构：
[1] OSAKA UNIV,SCH MED,INST CANC RES,DEPT ONCOGENESIS,FUKUSHIMA KU,OSAKA 553,JAPAN
来源：
BIKEN JOURNAL | 1984年 / 27卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 7
页数：7
相关论文
共 50 条
  • [1] PREVENTION OF SYNGENEIC TUMOR-GROWTH IN VACCINIA VIRUS-PRIMED MICE BY IMMUNIZATION WITH VACCINIA VIRUS-MODULATED TUMOR-CELLS
    WU, KS
    UEDA, S
    SAKAUE, Y
    OHASHI, Y
    IKUTA, K
    SUGANO, T
    KATO, S
    BIKEN JOURNAL, 1981, 24 (04) : 153 - 158
  • [2] AUGMENTED INDUCTION OF TUMOR-SPECIFIC RESISTANCE BY PRIMING WITH MYCOBACTERIUM-TUBERCULOSIS (TBC) AND SUBSEQUENT IMMUNIZATION WITH PPD-COUPLED SYNGENEIC TUMOR-CELLS
    TAKATSU, K
    HAMAOKA, T
    TOMINAGA, A
    KANAMASA, Y
    JOURNAL OF IMMUNOLOGY, 1980, 125 (06): : 2367 - 2373
  • [3] Thy1+ Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes
    Gillard, Geoffrey O.
    Bivas-Benita, Maytal
    Hovav, Avi-Hai
    Grandpre, Lauren E.
    Panas, Michael W.
    Seaman, Michael S.
    Haynes, Barton F.
    Letvin, Norman L.
    PLOS PATHOGENS, 2011, 7 (08)
  • [4] Redirected cellular cytotoxicity by infection of effector cells with a recombinant vaccinia virus encoding a tumor-specific monoclonal antibody
    Stéphane Paul
    Nadine Bizouarne
    Karine Dott
    Ludovic Ruet
    Patrick Dufour
    R Bruce Acres
    Marie Paule Kieny
    Cancer Gene Therapy, 2000, 7 : 615 - 623
  • [5] Redirected cellular cytotoxicity by infection of effector cells with a recombinant vaccinia virus encoding a tumor-specific monoclonal antibody
    Paul, S
    Bizouarne, N
    Dott, K
    Ruet, L
    Dufour, P
    Acres, RB
    Kieny, MP
    CANCER GENE THERAPY, 2000, 7 (04) : 615 - 623
  • [6] Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases
    Gnant, MFX
    Noll, LA
    Irvine, KR
    Puhlmann, M
    Terrill, RE
    Alexander, HR
    Bartlett, DL
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (20) : 1744 - 1750
  • [7] FEASIBILITY OF UV-INACTIVATED VACCINIA VIRUS IN THE MODIFICATION OF TUMOR-CELLS FOR AUGMENTATION OF THEIR IMMUNOGENICITY
    WAKAMIYA, N
    WANG, YL
    IMAI, H
    GU, HX
    UEDA, S
    KATO, S
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1986, 23 (02) : 125 - 129
  • [8] TUMOR-CELLS TREATED WITH VACCINIA VIRUS CAN ACTIVATE THE ALTERNATIVE PATHWAY OF MOUSE COMPLEMENT
    WAKAMIYA, N
    OKADA, N
    WANG, YL
    ITO, T
    UEDA, S
    KATO, S
    OKADA, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (08): : 765 - 770
  • [9] CONSTRUCTION AND EXPRESSION IN TUMOR-CELLS OF A RECOMBINANT VACCINIA VIRUS ENCODING HUMAN INTERLEUKIN-1-BETA
    PEPLINSKI, GR
    TSUNG, K
    WHITMAN, ED
    MEKO, JB
    NORTON, JA
    ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (02) : 151 - 159
  • [10] ESTABLISHMENT OF TUMOR-SPECIFIC IMMUNOTHERAPY MODEL UTILIZING VACCINIA VIRUS-REACTIVE HELPER T-CELL ACTIVITY
    SHIMIZU, Y
    HASUMI, K
    MASUBUCHI, K
    OKUDAIRA, Y
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (11) : 1773 - 1778
12345